Spring til hovednavigation
Spring til søgning
Spring til hovedindhold
Region Hovedstadens forskningsportal Forside
Dansk
English
!!Search content at Region Hovedstadens forskningsportal
Forside
Hospitaler/Afdelinger
Forskere
Publikationer
Aktiviteter
Priser
Sodium intake and multiple sclerosis activity and progression in BENEFIT
Kathryn C Fitzgerald
, Kassandra L Munger
, Hans-Peter Hartung
, Mark S Freedman
, Xavier Montalbán
, Gilles Edan
, Eva-Maria Wicklein
, Ernst-Wilhelm Radue
, Ludwig Kappos
, Christoph Pohl
, Alberto Ascherio
, BENEFIT Study Group
,
Jette Lautrup Battistini Frederiksen
(Medlem af forfattergruppering)
Afdeling for Hjerne- og Nervesygdomme
81
Citationer (Scopus)
Oversigt
Fingeraftryk
Fingeraftryk
Dyk ned i forskningsemnerne om 'Sodium intake and multiple sclerosis activity and progression in BENEFIT'. Sammen danner de et unikt fingeraftryk.
Sorter
Vægt
Alfabetisk
Keyphrases
Multiple Sclerosis
100%
Sodium Intake
100%
95% Confidence Interval
100%
Hazard Ratio
60%
Expanded Disability Status Scale
40%
5-year Follow-up
40%
Clinically Isolated Syndrome
40%
24-h Urinary Sodium Excretion
40%
Imaging Results
40%
Cardiac Magnetic Resonance Imaging (cMRI)
40%
Sodium Levels
40%
Urinary Sodium Excretion
40%
Non-associated
20%
Disease Course
20%
Disease Activity
20%
Multiple Sclerosis Treatment
20%
Relative Change
20%
Randomized Clinical Trial
20%
Disability
20%
Magnetic Resonance
20%
Clinically Definite multiple Sclerosis
20%
Relapse Rate
20%
Interferon beta-1a
20%
T2 Lesion Volume
20%
Spot Urine
20%
Active Lesions
20%
Categorical Data Analysis
20%
Salt Intake
20%
Urinary Sodium Concentration
20%
Cumulative Average
20%
Multiple Assessments
20%
Fast Conversions
20%
High-salt Diet
20%
Results-based
20%
Imaging Follow-up
20%
Mori-Tanaka Model
20%
Nursing and Health Professions
Multiple Sclerosis
100%
Sodium Intake
100%
Confidence Interval
83%
Sodium Urine Level
66%
Hazard Ratio
50%
Nuclear Magnetic Resonance Imaging
50%
Expanded Disability Status Scale
33%
Demyelinating Disease
33%
Disease Activity
16%
Urine Sampling
16%
Recurrence Risk
16%
Lesion Volume
16%
Interferon Beta Serine
16%
Disease Course
16%
Valerian
16%
Table Salt
16%
Clinical Trial
16%
Sodium
16%
Medicine and Dentistry
Multiple Sclerosis
100%
Sodium Intake
100%
Sodium Urine Level
66%
Hazard Ratio
50%
Magnetic Resonance Imaging
50%
Clinically Isolated Syndrome
33%
Expanded Disability Status Scale
33%
Sodium Excretion
33%
Disease Course
16%
Disease Activity
16%
Recurrence Risk
16%
Interferon Beta Serine
16%
Urine Sampling
16%
Valerian
16%
High Salt Diet
16%
Table Salt
16%
Randomized Clinical Trials
16%
Sodium
16%
Immunology and Microbiology
Multiple Sclerosis
100%
Sodium Urine Level
66%
Magnetic Resonance Imaging
50%
Clinically Isolated Syndrome
33%
Expanded Disability Status Scale
33%
Sodium Excretion
33%
Urine Sampling
16%
Interferon Beta 1b
16%
Lesion Volume
16%
Neuroscience
Multiple Sclerosis
100%
Magnetic Resonance Imaging
50%
Expanded Disability Status Scale
33%
Demyelinating Disease
33%
Interferon Beta 1b
16%
Valerian
16%